Search research articles
Contact Us
Filters
Showing results (291-300 of 651) with videos related to
Page
of 66
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 1, 1995
Characterization of a conjugative staphylococcal mupirocin resistance plasmid
T M Morton, J L Johnston, J Patterson, et al.
The Journal of Infectious Diseases
|
June 1, 1984
Plasmid-pattern analysis for the differentiation of infecting from noninfecting Staphylococcus epidermidis
G L Archer, A W Karchmer, N Vishniavsky, et al.
Anesthesia and Analgesia
|
August 20, 2009
Stroke volume calculation by esophageal Doppler integrates velocity over time and multiplies this "area under the curve" by the cross sectional area of the aorta
Thomas L Archer, Duane J Funk, Eugene Moretti, et al.
Gut
|
June 1, 1981
Fasting motor activity occurs during a day of normal meals in healthy subjects
D G Thompson, L Archer, W J Green, et al.
The European Respiratory Journal
|
July 1, 1996
Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysis
V Hampl, M Tristani-Firouzi, D P Nelson, et al.
Histopathology
|
July 4, 2012
Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension
Jennifer E Pogoriler, Stuart Rich, Stephen L Archer, et al.
Journal of Molecular and Cellular Cardiology
|
December 2, 2004
Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells
Evangelos D Michelakis, Bernard Thébaud, E Kenneth Weir, et al.
Cells
|
November 10, 2023
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
Isaac M Emon, Ruaa Al-Qazazi, Michael J Rauh, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2003
Paroxetine-induced increase in metabolic end products of nitric oxide
Nathalie Lara, Stephen L Archer, Glen B Baker, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin
R L Patron, M W Climo, B P Goldstein, et al.
Page
of 66
Search research articles
Search
Showing results (291-300 of 651) with videos related to
Sort By:
Page
of 66
Antimicrobial Agents and Chemotherapy
|
June 1, 1995
Characterization of a conjugative staphylococcal mupirocin resistance plasmid
T M Morton, J L Johnston, J Patterson, et al.
The Journal of Infectious Diseases
|
June 1, 1984
Plasmid-pattern analysis for the differentiation of infecting from noninfecting Staphylococcus epidermidis
G L Archer, A W Karchmer, N Vishniavsky, et al.
Anesthesia and Analgesia
|
August 20, 2009
Stroke volume calculation by esophageal Doppler integrates velocity over time and multiplies this "area under the curve" by the cross sectional area of the aorta
Thomas L Archer, Duane J Funk, Eugene Moretti, et al.
Gut
|
June 1, 1981
Fasting motor activity occurs during a day of normal meals in healthy subjects
D G Thompson, L Archer, W J Green, et al.
The European Respiratory Journal
|
July 1, 1996
Chronic infusion of nitric oxide in experimental pulmonary hypertension: pulmonary pressure-flow analysis
V Hampl, M Tristani-Firouzi, D P Nelson, et al.
Histopathology
|
July 4, 2012
Persistence of complex vascular lesions despite prolonged prostacyclin therapy of pulmonary arterial hypertension
Jennifer E Pogoriler, Stuart Rich, Stephen L Archer, et al.
Journal of Molecular and Cellular Cardiology
|
December 2, 2004
Hypoxic pulmonary vasoconstriction: redox regulation of O2-sensitive K+ channels by a mitochondrial O2-sensor in resistance artery smooth muscle cells
Evangelos D Michelakis, Bernard Thébaud, E Kenneth Weir, et al.
Cells
|
November 10, 2023
The Role of Clonal Hematopoiesis of Indeterminant Potential and DNA (Cytosine-5)-Methyltransferase Dysregulation in Pulmonary Arterial Hypertension and Other Cardiovascular Diseases
Isaac M Emon, Ruaa Al-Qazazi, Michael J Rauh, et al.
Journal of Clinical Psychopharmacology
|
August 16, 2003
Paroxetine-induced increase in metabolic end products of nitric oxide
Nathalie Lara, Stephen L Archer, Glen B Baker, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin
R L Patron, M W Climo, B P Goldstein, et al.
Page
of 66